SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.27%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$501M
AUM Growth
+$501M
(+27%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
29.64%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
285
New
86
Increased
57
Reduced
47
Closed
30
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$35.7M |
| 2 |
Biogen
BIIB
|
$22.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 4 |
Viatris
VTRS
|
$15.2M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.5M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$28.9M |
| 2 |
Merck
MRK
|
$17.9M |
| 3 |
Exxon Mobil
XOM
|
$14.8M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10M |
| 5 |
Gevo
GEVO
|
$7.36M |
Sector Composition
| 1 | Healthcare | 64.78% |
| 2 | Energy | 5.21% |
| 3 | Technology | 2.24% |
| 4 | Materials | 2.17% |
| 5 | Consumer Discretionary | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Russell 2000 ETF
IWM
$67B
| $35.7M | 1.47% | +327,168 | New | +$35.7M |
|
|
2
Biogen
BIIB
$19.4B
| $22.9M | 0.95% | +78,629 | New | +$22.9M |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $18.3M | 0.76% | +174,073 | New | +$18.3M |
|
|
4
Viatris
VTRS
$12.3B
| $15.2M | 0.63% | +376,827 | New | +$15.2M |
|
|
PXD
5
DELISTED
Pioneer Natural Resource Co.
PXD
| $15M | 0.62% | 123,600 +47,327 | +62% | +$5.76M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.5M | 0.6% | +342,857 | New | +$14.5M |
|
|
IOC
7
DELISTED
Interoil Corporation
IOC
| $11.1M | 0.46% | 328,705 +175,561 | +115% | +$5.92M |
|
8
Edwards Lifesciences
EW
$47.8B
| $11M | 0.45% | 77,255 +59,440 | +334% | +$8.45M |
|
|
MBLY
9
DELISTED
Mobileye N.V.
MBLY
| $10.7M | 0.44% | 235,819 +161,987 | +219% | +$7.37M |
|
|
10
Gevo
GEVO
$418M
| $9.82M | 0.4% | 100,000 -75,000 | -43% | -$7.36M |
|
11
Tenet Healthcare
THC
$16.3B
| $9.08M | 0.37% | +245,938 | New | +$9.08M |
|
12
Tenax Therapeutics
TENX
$27.3M
| $7.89M | 0.33% | 2,604,660 -81,587 | -3% | -$247K |
|
13
Agios Pharmaceuticals
AGIO
$2.19B
| $7.73M | 0.32% | +109,521 | New | +$7.73M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $7.73M | 0.32% | 49,397 +33,502 | +211% | +$5.24M |
|
|
KITE
15
DELISTED
Kite Pharma, Inc.
KITE
| $7.63M | 0.31% | 137,099 +133,427 | +3,634% | +$7.43M |
|
16
Eledon Pharmaceuticals
ELDN
$155M
| $6.77M | 0.28% | 654,283 +526,242 | +411% | +$5.45M |
|
|
BPMC
17
DELISTED
Blueprint Medicines
BPMC
| $6.58M | 0.27% | 308,504 +6,700 | +2% | +$143K |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.56M | 0.27% | 71,757 +53,352 | +290% | +$4.87M |
|
|
APC
19
DELISTED
Anadarko Petroleum
APC
| $6.18M | 0.25% | 102,300 +11,329 | +12% | +$684K |
|
|
VXZ
20
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $5.86M | 0.24% | 450,500 +500 | +0.1% | +$6.51K |
|
21
Exact Sciences
EXAS
$8.98B
| $5.2M | 0.21% | +289,112 | New | +$5.2M |
|
22
Opko Health
OPK
$1.1B
| $5.17M | 0.21% | 615,157 +392,031 | +176% | +$3.3M |
|
23
Standard BioTools
LAB
$481M
| $5.1M | 0.21% | 628,260 +462,875 | +280% | +$3.75M |
|
|
GNCA
24
DELISTED
Genocea Biosciences, Inc.
GNCA
| $5M | 0.21% | 729,141 +560,561 | +333% | +$3.84M |
|
|
ALPN
25
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $4.99M | 0.21% | 384,734 -45,307 | -11% | -$588K |
|